Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19

Conflicting evidence regarding the use of hydroxychloroquine (HCQ) and azithromycin for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection do exist. We performed a retrospective single‐center cohort study including 377 consecutive patients admitted for pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauriola, Marinella, Pani, Arianna, Ippoliti, Giovanbattista, Mortara, Andrea, Milighetti, Stefano, Mazen, Marjieh, Perseghin, Gianluca, Pastori, Daniele, Grosso, Paolo, Scaglione, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719367/
https://www.ncbi.nlm.nih.gov/pubmed/32926573
http://dx.doi.org/10.1111/cts.12860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719367/
https://www.ncbi.nlm.nih.gov/pubmed/32926573
http://dx.doi.org/10.1111/cts.12860

Ejemplares similares